Key Takeaways

• California’s Corporate Practice of Medicine doctrine is a licensing framework applied to the function of the business, not a payor-mix framework, a geographic framework, or a marketing-label framework.
• Cash-pay operation, mobile delivery, wellness positioning, and RN ownership do not exempt a business from CPOM analysis. Each of these framings is a specific myth the seller may present as a compliance shortcut and each one collapses on inspection.
• The California AG’s 2026 enforcement actions (Aspen Dental, Carbon Health, the Art Center Holdings amicus brief) demonstrated that CPOM enforcement reaches structures the industry sometimes considered “gray area.” Buyers should not rely on informal industry practice as evidence of compliance.
• Buyers who catch these misconceptions during diligence can either walk away from targets structured around them or restructure the deal to fix the underlying compliance problem. Buyers who close on the seller’s misconception inherit the exposure.

“It’s All Cash-Pay, So CPOM Doesn’t Apply” — and 4 Other Myths That Kill Deals

Non-licensee buyers of California treatment businesses encounter the same set of misconceptions in almost every deal. Some come from sellers who genuinely believe them. Some come from sellers who know better and hope the buyer does not. Some come from formation-service kits and franchise-system playbooks that were designed for permissive states and never updated for California. All of them share one feature: they are wrong, and each of them, taken as diligence gospel, sets the buyer up to close a deal that will not survive scrutiny.

This post covers the five most persistent CPOM myths that show up in California treatment-business acquisitions — what the myth says, why it is wrong, and what the buyer should do about it. Read it before your next LOI.

Myth 1: “It’s All Cash-Pay, So CPOM Doesn’t Apply”

What the seller says. “We do not bill insurance. Patients pay us directly. Because there are no payors involved, CPOM does not apply to our business. That is why our LLC works.”

Why it is wrong. California’s Corporate Practice of Medicine doctrine is a licensing framework, not a payor framework. B&P § 2052 prohibits unlicensed practice of medicine regardless of who pays for it. B&P § 2400 prohibits corporations from having professional rights or powers regardless of billing arrangements. The Moscone-Knox Professional Corporation Act reserves ownership of medical corporations to licensed physicians regardless of the practice’s revenue mix. Cash payment does not change what the practice does, what services are being rendered, or whether the entity rendering them is lawfully authorized to do so.

The seller is describing an operational feature (payor mix) as if it were a legal exemption (from CPOM). It isn’t.

Cash-pay operation does have real implications elsewhere in the analysis — the payor-transition mechanics on acquisition are simpler, the Medicare CHOW analysis under 42 C.F.R. § 489.18 typically does not apply, and payor-recoupment exposure for historical non-compliance is limited. But none of those implications reach the underlying CPOM question. The clinical entity still has to be a physician-owned professional corporation; the LLC still cannot render medical services under Cal. Corp. Code § 17701.04(e); and the good-faith exam requirement under B&P § 2242 still applies before treatment.

What to do about it. Structure the deal for CPOM compliance regardless of payor mix. If the seller has been operating a cash-pay practice through an LLC on the assumption that cash-pay exempts CPOM, the target has both a going-forward structural defect and historical exposure the diligence needs to allocate.

Myth 2: “We’re Mobile, So It’s Different”

What the seller says. “We are not a brick-and-mortar clinic. We do IV therapy at hotels, weddings, and clients’ homes. The mobile model has its own rules. CPOM is really about clinics.”

Why it is wrong. There is no mobile carve-out from California CPOM, from the good-faith exam requirement, or from standardized procedures. The compliance framework applies to what the business does — administering medical treatment to patients — not to the geography of where the business does it. Bay Legal’s existing IV hydration content has been explicit on this point since publication, and California Medical Board and BRN enforcement has treated mobile operations as subject to the same clinical structure requirements as brick-and-mortar clinics.

Mobile operations add operational-safety, insurance, and emergency-response considerations that brick-and-mortar clinics do not face. Standard professional liability policies for brick-and-mortar practices may not cover mobile administration. Emergency response for adverse reactions in a client’s home requires documented protocols. Waste disposal and controlled-substance transport have their own requirements. But none of these operational differences reach the CPOM analysis. The clinical entity still has to be a physician-owned PC; the good-faith exam still has to happen (in person or by synchronous video for compliant telehealth GFE); the standardized procedures still have to be current and specific to the actual mobile operations under 16 CCR § 1474.

What to do about it. Treat mobile operations as regular healthcare businesses with additional operational complexity, not as retail wellness with lighter compliance. The mobile-specific diligence issues (safety infrastructure, insurance coverage, emergency response protocols, transport and storage compliance) sit on top of the standard CPOM diligence framework, not in place of it.

Myth 3: “It’s Wellness, Not Medical”

What the seller says. “This is not a medical practice. It is a wellness studio. Recovery lounge. Longevity center. Anti-aging clinic. We do not diagnose or treat diseases. Our clients are healthy people who want to feel better. Different rules apply to wellness.”

Why it is wrong. California CPOM applies functionally. B&P §§ 2052 and 2400 reach the practice of medicine as a matter of what the business does, not what the business calls itself. Administering prescription drugs (IV vitamins, IV medications, hyperbaric oxygen, semaglutide, ketamine, testosterone) is the practice of medicine. Using FDA-regulated Class II medical devices (hyperbaric chambers, medical-grade lasers) on patients is the practice of medicine. Prescribing anything requiring a prescription — legend drugs, controlled substances, medical-device treatment — is the practice of medicine. The “wellness” or “longevity” label does not change any of that.

The label matters for marketing, and marketing that positions a practice as “wellness” while it administers medical treatment creates a separate exposure category under B&P § 17500 (false advertising) and the Unfair Competition Law. Practices that promise specific outcomes for off-label indications — cognitive enhancement, immune boosting, athletic recovery, hangover cure, weight loss beyond FDA-labeled indications, face both CPOM exposure (they are still medical practices) and false-advertising exposure (the claims outrun the evidence). Wellness framing adds a compliance layer to the CPOM analysis; it does not remove one.

What to do about it. Structure the deal for CPOM compliance regardless of marketing framing. If the seller has been positioning a medical practice as “wellness” to avoid what the seller perceives as medical-practice compliance burden, the target has both a going-forward structural defect and historical marketing exposure that needs allocation.

Myth 4: “The RN Owns the Business and Runs Everything”

What the seller says. “This is a nurse-led practice. Our founder is an experienced RN with decades of injectable and IV therapy experience. She owns the business. Our medical director signs off on protocols, but the RN runs day-to-day. This is how nurse entrepreneurs build their businesses in California.”

Why it is wrong. Registered nurses cannot own California medical corporations. Cal. Corp. Code § 13401.5(a) lists the specific categories of allied professionals who can hold up to 49% of a medical corporation as minority shareholders — RNs are not on the list. Even as a minority shareholder, an RN cannot participate in the ownership of a California medical corporation.

RNs can own MSOs, and RN-owned MSOs contracting with physician-owned PCs is the standard structure for nurse entrepreneurs in California IV hydration, med spa, and wellness practices. That is a compliant structure. What is not compliant is an RN-owned entity that renders medical services directly — whether the entity is styled as an LLC (which cannot render medical services under Cal. Corp. Code § 17701.04(e)), a general business corporation, or a professional corporation with the RN as a shareholder.

The distinction matters. An RN who owns an MSO that contracts with a physician-owned PC is participating in California healthcare through the compliant path. An RN who owns the entity that treats patients — whatever the entity is called, is operating outside the framework and has both an ongoing CPOM defect and a potential Board of Registered Nursing exposure for practicing outside the appropriate delegation framework.

What to do about it. Structure the acquisition as the buyer’s MSO acquiring the non-clinical assets and the physician-partner’s new PC acquiring the clinical assets. If the RN founder wants to continue in the business, the compliant continuation is: the RN owns the MSO (either alone or jointly with the buyer), and the RN works clinically as an employee of the PC. That is a viable path in most transactions.

Myth 5: “The Franchise System’s MSA Is Approved for California”

What the seller says. “This is a franchise. The franchise system has thousands of locations. Their attorneys have already approved the MSA for California. We use the standard operating agreements. Everything is compliant.”

Why it is wrong. California MSA compliance is not something a national franchise system can approve for the state by drafting a standard-form template. California CPOM analysis is fact-intensive; SB 351 (effective January 1, 2026) adds specific contract restrictions on PE- and hedge fund-affiliated MSAs; the California AG’s June 2026 Carbon Health settlement identified specific MSA arrangements the AG considers per se impermissible; and the Epic Medical Management, LLC v. Paquette / B&P § 650(b) FMV requirements apply to the specific practice, not to a template.

MSA templates that have been drafted for use in Texas, Florida, Delaware, and other permissive-to-medium states routinely fail one or more of the California-specific requirements. Templates that provide MSO authority over clinician hiring and firing, that use percentage-of-revenue fees without FMV support, that give the MSO an assignable option over PC ownership, that include non-compete or non-disparagement clauses in physician employment agreements, or that structure MSO financing to the PC as exclusive above-market credit arrangements — all of these are common in franchise-system and formation-service templates, and all of them are problematic under 2026 California standards.

What to do about it. Have California-specific healthcare counsel review the existing MSA against Bay Legal’s benchmark framework: (a) Epic / B&P § 650(b) FMV requirements for the management fee; (b) SB 351 contract restrictions (non-compete and non-disparagement); (c) Carbon Health benchmarks (no assignable options, no exclusive above-market financing, no MSO personnel authority over clinical staff, no MSO control over advertising, payor negotiations, and equipment selection); (d) AB 1415 notice obligations for MSO transactions. Where the existing MSA fails any of these, the buyer’s post-closing structure needs an MSA rebuild — often as part of the closing transition rather than deferred.

Two Related Misconceptions Worth Noting

Beyond the five myths above, two related misconceptions come up frequently enough to warrant a note.

“The medical director covers everything.” A medical director agreement does not substitute for a physician-owned clinical entity. The medical director is an operational role within a compliant structure, not a compliance workaround for a defective one. A practice that operates through an LLC with a medical director on paperwork has both a defective structure (the LLC cannot render medical services) and often a defective medical director arrangement (paper medical directors are a frequent focus of Medical Board enforcement).

“We will fix it once we scale.” Compliance built at scale is materially harder and more expensive than compliance built at inception. Practices that plan to “get compliant when we have the revenue to justify it” typically discover that the historical exposure accumulated during the non-compliant period is disproportionate to the eventual cost of doing it right, and that the physician-partner sourcing and MSA drafting take longer once patient volume and staff complexity have grown. Structure at inception; refine at scale.

When to Bring Counsel Into the Diligence

Before the LOI is signed. The five myths above are exactly the misconceptions California-specific counsel identifies in pre-LOI diligence. Catching them post-LOI is disruption; catching them pre-LOI is architecture.

Bay Legal, PC represents non-licensee buyers of California treatment businesses. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

Frequently Asked Questions

Does California CPOM really apply to cash-pay businesses?

Yes. California’s Corporate Practice of Medicine doctrine is a licensing framework, not a payor framework. B&P §§ 2052 and 2400 and the Moscone-Knox Professional Corporation Act apply regardless of whether the practice bills insurance, cash, membership fees, or a combination. Payor mix affects the payor-transition analysis on acquisition and the payor-recoupment exposure for historical non-compliance, but does not affect the underlying CPOM question.

Does the mobile-operation model change the compliance analysis?

No. There is no mobile carve-out from CPOM, the good-faith exam requirement, or standardized procedures. Mobile operations face additional operational-safety, insurance, and emergency-response considerations that brick-and-mortar practices do not face, but the CPOM structural requirements apply equally.

If the practice markets itself as “wellness,” is it still subject to CPOM?

Yes, if the practice administers prescription drugs, uses FDA-regulated medical devices on patients, or prescribes anything requiring a prescription. California CPOM applies functionally — to what the business does, not what it calls itself. Wellness marketing that promises specific outcomes for off-label indications can add a separate false-advertising exposure category under B&P § 17500 alongside the underlying CPOM issue.

Can an RN own a California IV hydration or med spa business?

An RN can own an MSO that contracts with a physician-owned PC providing the clinical services. An RN cannot own the professional corporation that renders the medical services — that ownership is limited to licensed physicians (and, in specific configurations, minority allied-professional shareholders under Cal. Corp. Code § 13401.5(a); RNs are not on the list of allied shareholders permitted for medical corporations). The RN-as-MSO-owner path is the standard structure for nurse entrepreneurs in California.

How do I know if the target’s franchise-system MSA is California-compliant?

Have California-specific healthcare counsel review it against the framework the 2026 AG enforcement pattern established: FMV support for the management fee under Epic and B&P § 650(b); no assignable options over PC ownership; no exclusive above-market financing arrangements; no MSO personnel authority over clinical staff hiring, firing, or compensation; no MSO control over advertising, payor negotiations, and equipment selection where those functions bear on clinical decisions; SB 351 compliance for PE- and hedge fund-affiliated MSAs (non-compete and non-disparagement provisions); and any applicable AB 1415 notice obligations for the MSO transaction itself.

Talk to a California Healthcare Acquisition Attorney

Bay Legal, PC represents non-licensee buyers of California treatment businesses through pre-LOI structuring counsel, CPOM diligence, and deal documentation. If you are evaluating a target and want to catch the compliance misconceptions before they close, ccall (650) 668-8000 or schedule a consultation at baylegal.com/contact.